1. Conditional recurrence after 5-years of hormone therapy in estrogen positive breast cancer. (April 2018) Authors: Vane, M.; Van Roozendaal, L.; Moossdorff, M.; Engelen, S.; Siesling, S.; Smidt, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidence of local recurrence in relation to radiotherapy and trastuzumab in early Her2 positive breast cancer. (April 2018) Authors: Traa, F.; Vane, M.; Van Roozendaal, L.; Heuts, E.; Siesling, S.; Moossdorff, M.; Smidt, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Staging in estrogen receptor positive breast tumors: Pathological staging versus bioscore. (April 2018) Authors: Traa, F.; Van Kuijk, S.; Vane, M.; Engelen, S.; Van Kaathoven, B.; Siesling, S.; Van Maaren, M.; Moossdorff, M.; Smidt, M. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The gene expression profile in clinically node negative T1–2 breast cancer patients: Its additional value in case of sentinel lymph node biopsy is not performed. (October 2020) Authors: Colier, E.; Vane, M.; Roozendaal, L.; de Boer, M.; Siesling, S.; Smidt, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗